# VOLT CE Mark Study

> **NCT06106594** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Abbott Medical Devices** · enrollment: 300 (estimated)

## Conditions studied

- Atrial Arrhythmia
- Atrial Fibrillation
- Paroxysmal Atrial Fibrillation
- Persistent Atrial Fibrillation

## Interventions

- **DEVICE:** Pulsed Field Ablation

## Key facts

- **NCT ID:** NCT06106594
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-10-24
- **Primary completion:** 2026-06
- **Final completion:** 2026-12
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06106594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06106594, "VOLT CE Mark Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06106594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*